This invention relates to novel substituted aryloxy alkylamines useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

 
Web www.patentalert.com

< Methods for Enhancing the Quality of Life of a Senior Animal

> Crosslinked Polyalkyleneimine Hydrogels with Tunable Degradation Rates

> Glp-1 Pegylated Compounds

~ 00539